A detailed history of Superstring Capital Management LP transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Superstring Capital Management LP holds 83,554 shares of BMEA stock, worth $538,087. This represents 0.74% of its overall portfolio holdings.

Number of Shares
83,554
Previous 167,110 50.0%
Holding current value
$538,087
Previous $752 Million 12.22%
% of portfolio
0.74%
Previous 0.95%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.23 - $10.1 $353,441 - $843,915
-83,556 Reduced 50.0%
83,554 $844 Million
Q2 2024

Aug 14, 2024

BUY
$4.14 - $15.3 $691,835 - $2.56 Million
167,110 New
167,110 $752 Million

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $189M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Superstring Capital Management LP Portfolio

Follow Superstring Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Superstring Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Superstring Capital Management LP with notifications on news.